189825-46-5

Upstream product

• 617-04-9 (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 131089-34-4 3-O-benzoyl-6-O-(t-butyldiphenyl)silyl-α-D-mannopyranoside 

Downstream Products

• 172688-51-6 Trifluoro-methanesulfonic acid (3aS,4S,6R,7S,7aR)-6-(tert-butyl-diphenyl-silanyloxymethyl)-4-methoxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 172688-29-8 methyl 4-azido-4-deoxy-6-O-tert-butyldiphenylsilyl-2,3-O-isopropylidene-α-D-mannopyranoside 
• 172688-33-4 (5R,6S,7R)-5,6,7trihydro-5-(1R-1,2-dihydroxyethyl)-6,7-O-isopropylidenepyrrolo<1,2-d>tetrazole-6,7-diol 
• 189825-47-6 methyl 6-O-(tert-butyldiphenylsilyl)-2,3-O-isopropylidene-4-deoxy-4-methylene-α-D-lyxo-hexopyranoside 
• 172688-48-1 methyl 6-O-tert-butyldiphenylsilyl-2,3-O-isopropylidene-α-D-talopyranoside 
• 189825-48-7 C₅₀H₇₁NO₁₀Si₂ 
• 189825-49-8 C₄₂H₆₇NO₉Si₂ 

Relevant academic research and scientific papers

Tetrazoles of manno- and rhamno-furanoses

The synthesis of tetrazoles derived from D-mannofuranose and both enantiomers of rhamnofuranose provides the first examples of tetrazole analogues of carbohydrates in the furanose form. The D-furanotetrazoles are potential mannosidase inhibitors whereas the L-rhamnotetrazole may interfere with the biosynthesis of cell walls of mycobacteria and provide a strategy for the treatment of tuberculosis and leprosy.